1999
DOI: 10.1099/0022-1317-80-3-563
|View full text |Cite
|
Sign up to set email alerts
|

Development of porcine adenovirus-3 as an expression vector.

Abstract: Porcine adenovirus-3 (PAV-3) was developed as an expression vector using homologous recombination in Escherichia coli BJ 5183. As a prerequisite, the complete genome of PAV-3 was first introduced as a PacI restriction fragment into a bacterial plasmid. The plasmid, when PacI restricted and transfected into swine testicular cells, produces an infectious virus. The potential of this procedure was demonstrated by the construction of several PAV-3 recombinants. Part of the E3 region, which is nonessential for viru… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
58
0

Year Published

2000
2000
2010
2010

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 63 publications
(59 citation statements)
references
References 29 publications
1
58
0
Order By: Relevance
“…The PAV isolates found in this study were highly similar to the previously described PAV3 IAF strain (26). This is a strain derived from PAV3 strain 6618 and adapted to pig kidney cells and which has been isolated in several countries (10,14).…”
Section: Discussionsupporting
confidence: 79%
“…The PAV isolates found in this study were highly similar to the previously described PAV3 IAF strain (26). This is a strain derived from PAV3 strain 6618 and adapted to pig kidney cells and which has been isolated in several countries (10,14).…”
Section: Discussionsupporting
confidence: 79%
“…An alternative strategy to circumvent preexisting anti-Ad immunity is the use of nonhuman Ad serotypes (5,13,14,26,33,38,40,43,44,48,49,51,(59)(60)(61). Nonhuman primatederived Ad vaccine vectors were developed to overcome preexisting immunity to common human Ad serotypes and to broaden the repertoire of Ad vaccines for booster immunizations.…”
Section: Discussionmentioning
confidence: 99%
“…It is widely used for the propagation of HAV5 recombinants with E1 deleted (5,16). In addition to HAVs, a number of nonhuman adenoviruses, such as bovine adenovirus type 3 (BAV3) (37), canine adenovirus type 2 (28), porcine adenovirus type 3 (45), and ovine adenovirus (23), have been developed as vectors for producing recombinant vaccines and also for their potential use in gene therapy.…”
mentioning
confidence: 99%